-
Vaccines, Blood & Biologics
-
Resources for You
-
-
Adacel
Proper Name: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed
Tradename: Adacel
Manufacturer: Sanofi Pasteur, Ltd, License #1726
Indication:
- Booster immunization against tetanus, diphtheria and pertussis as a single dose in individuals 11 through 64 years of age
-
Supporting Documents
- January 16, 2009 Approval Letter - Adacel
Package Insert Revision: To revise the package insert to include revision of the placement of infonnalion regarding latex content of the product. - March 18, 2008 Approval Letter - Adacel
To include unit dose syringes as an alternate presentation. - June 10, 2005 Approval Letter - Adacel
Indication: Booster immunization against tetanus, diphtheria and pertussis as a single dose in individuals 11 through 64 years of age. - FDA Approves a New Combination Vaccine to Help Protect Both Adolescents and Adults against Whooping Cough
Press Release: 6/10/2005
-
Contact Us
Consumer Affairs Branch (CBER)
- (800) 835-4709
- (301) 827-1800
- ocod@fda.hhs.gov
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-
-